-
Ex-F1 driver turned Paralympic champion Zanardi dies
-
In Vietnam, Japan PM vows more effort to keep Asia 'free and open'
-
Humpback whale stranded in Germany released into North Sea: media
-
Japan PM meets top Vietnam leaders in Hanoi
-
Spirit Airlines begins 'wind-down', cancels all flights
-
Japan PM to meet top Vietnam leaders in Hanoi
-
Raisin moonshine banned in Iran enjoys resurgence in New York
-
Lebanon says 13 killed in Israeli strikes in south
-
No.1 Korda charges into share of LPGA Mexico lead
-
Young fires 67 to seize commanding PGA lead at Doral
-
US appeals court temporarily halts mail delivery of abortion pill
-
Joy for Norris in Miami as McLaren end Mercedes run
-
Leclerc offers hope to Ferrari fans in Miami
-
US to withdraw about 5,000 troops from Germany
-
'No going back' for Colombia's workers as the right eyes return
-
Norris on sprint pole as McLaren shine again
-
Venezuelan protesters call government wage hike a joke
-
Leeds beat Burnley to virtually secure Premier League survival
-
Gridlock as pandemic treaty talks fail to finish
-
S&P 500, Nasdaq end at fresh records on tech earnings strength
-
Immersive art: museum-goers in bikinis dive into Cezanne
-
Gaza activists disperse after flotilla halted by Israel off Crete
-
US sanctions are 'collective punishment,' says Cuba during May 1 marches
-
Delhi end slump with team-record chase against Rajasthan
-
Trump says will raise US tariffs on EU cars to 25%
-
AI actors and writers not eligible for Oscars: Academy
-
Rebels take key military base in Mali's north
-
ExxonMobil CEO sees chance of higher oil prices as earnings dip
-
Leclerc on top for Ferrari ahead of Verstappen and Piastri
-
Trump says 'not satisfied' with new Iran proposal
-
After Madonna and Lady Gaga, Shakira set for Rio beach mega-gig
-
Trump says will raise US tariffs on EU cars, trucks to 25%
-
Godon raises game to take Romandie stage and revenge over leader Pogacar
-
Celtic's O'Neill expects no let-up from Hibs despite fans' feelings
-
Pope names former undocumented migrant as US bishop
-
Javelin star Kitaguchi teams up with Czech legend Zelezny
-
Sawe sub-2hr marathon captured 'global imagination' says Coe
-
King Charles gets warm welcome in Bermuda after whirlwind US visit
-
Sinner shines to beat Fils, reach Madrid Open final
-
UK court clears comedy writer of damaging transgender activist's phone
-
Was LIV Golf an expensive failure for Saudis? Not everyone thinks so
-
Coe hails IOC gender testing decision
-
McInnes wants Tynecastle in 'full glory' for Hearts title charge
-
McFarlane says troubled Chelsea still attractive to potential managers
-
Man Utd boss Carrick relishes 'special' Liverpool rivalry
-
Baguettes take centre stage on France's Labour Day
-
Spurs must banish 'loser' mentality despite injury woes, says De Zerbi
-
Arsenal must manage emotions of title race says Arteta
-
Nepal temple celebrates return of stolen Buddha statue
-
US Fed official says rate hikes may be needed if inflation surges
Japan drugmaker reports two more deaths in supplement scare
A Japanese drugmaker whose dietary supplements are at the centre of a growing health scare reported on Thursday two more deaths potentially related to its tablets.
Last week, Kobayashi Pharmaceutical recalled three supplement brands -- "Beni Koji Choleste Help" and two others -- after customer complaints of kidney problems.
The over-the-counter products contain an ingredient called red yeast rice, or "beni koji", which is supposed to help lower cholesterol.
Thursday's announcement brings the total number of deaths under investigation by the company and health ministry to four, with more than 100 other people hospitalised.
"We were told yesterday by a bereaved family that a person who had been using Choleste Help had passed away due to kidney disease," the drugmaker said in a statement.
It added it had been told separately that another person who had used Choleste Help in recent years had died.
"We are in the process of confirming the facts and causal relationships in both of these cases," the statement said.
"However, we decided to make this report public from the viewpoint of prompt disclosure."
Medical studies describe red yeast rice as an alternative to statins for lowering high cholesterol, but also warn of a risk of organ damage depending on its chemical make-up.
Kobayashi Pharmaceutical sells a wide range of health products marketed through television adverts in Japan.
The Osaka-based company says it has also supplied red yeast rice to around 50 other firms in Japan and two in Taiwan.
Government spokesman Yoshimasa Hayashi said Thursday that authorities were doing "their utmost to ensure food safety, including identifying the substance that caused the health harm and how it became present in the product".
The government has ordered various health-food makers to review their products, while informing foreign countries about the issue through Japan's embassies, he said.
Dozens of Japanese firms that used beni koji provided by Kobayashi Pharmaceutical have also separately announced recalls.
The affected products include health tablets as well as a rose-coloured sparkling sake, salad dressing, bread and miso paste used in many traditional dishes.
Kobayashi Pharmaceutical has said analysis had found a possibility that the products contained "ingredients we had not intended to include".
But it said it did not find any citrinin produced by red yeast rice, which is toxic and can damage the kidneys.
R.Flueckiger--VB